A Conversation with Acromegaly Patient Advocates

We recently sat down with members of the acromegaly community to discuss their treatment journeys and the lessons they learned along the way, including...

A new drug for acromegaly: an insider’s look at the clinical trial

With the recent launch announcement of the phase 3 trial for Paltusotine - Crinetics new nonpeptide oral drug candidate for acromegaly - we asked...

Canada to Mexico: Rare pituitary disease patient bikes the 1845-mile Pacific Coast Highway

My conversation with Risa Heidt, who will be riding her bike from Canada to Mexico to promote awareness of rare pituitary diseases: Marisa "Risa"...

Acromegaly: the last 30 years

In this Podcast, Dr. Blevins gives us a perspective of the last 30 years on the developments in this field. Like many other conditions, the advances in therapy, imaging, surgery techniques, diagnostic testing, and clinical knowledge have been nothing short of remarkable.

When 304 people, including 128 living with acromegaly, gather to talk about the disease,...

In January 2021, the Acromegaly Community, a US-based patient advocacy organization, organized and participated in an externally lead patient focus drug development meeting. The EL-PFDD...

Supporting a new diagnosis of Acromegaly

We continue to showcase Pfizer’s new series on patient support.  This brochure offers great advice on how to deal with a new acromegaly diagnosis....

NEWS YOU CAN USE

Articles you may like